© Copyright Esol link
Single-Use
Bioreactors Market in terms of revenue was estimated to be worth $4.2
billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR
of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Factors such as the increasing adoption of single-use
bioreactors among startups and SMEs, lower operational complexity of single-use
bioreactors compared to conventional stainless-steel bioreactors, reduced
energy and water consumption, growing size of the biologics and biosimilars
market, and technological advancements in single-use bioreactors.
Browse in-depth TOC on "Single-Use Bioreactors
Market"
408 - Tables
48 - Figures
345 – Pages
TOP Single-Use Bioreactors MARKET PLAYER
The single-use bioprocessing market is highly consolidated
with majority of the market share taken up by key players such as Thermo Fisher
Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A.
(France), and Merck KGaA (Germany). The key players in this market are
increasingly focusing on strategic expansions, partnerships, and product
approvals to expand their manufacturing capabilities and increase market
presence.
Sartorius Stedim Biotech held the
leading position in the single-use bioprocessing market. Sartorius focuses on
strengthening its position in the market by adopting organic and inorganic
strategies such as product launches and expansions. During the past three
years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR
Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and
BIOSTAT STR. Sartorius acquired Danaher’s Life Science portfolio, which is
complementary to the portfolio of Sartorius’s laboratory and bioprocess
business. the company also expanded their operations in Puerto Rico.
Thermo Fisher Scientific is the
second-largest player in the single-use bioprocessing market. Thermo Fisher
Scientific operates in the single-use bioprocessing market through the life
science solutions business segment. To further increase its share in the
single-use bioprocessing market, the company focuses on growth strategies such
as acquisitions and expansion. the company expanded its business in the US. The
company also made investments worth ~USD 650 million to enhance their
single-use bioprocessing capabilities and increase their market share.
The Asia Pacific region is the fastest-growing region of
the single-use bioreactors market.
Based on the region, the single-use bioreactors market is
segmented into five major regions: North America, Europe, Asia Pacific, Latin
America, and the Middle East & Africa. The Asia Pacific market is expected
to register the highest CAGR during the forecast period. Factors such as the
growing biopharmaceutical industry, rising investments by pharmaceutical &
biotechnology companies, and the growing number of CROs & CMOs in several
Asia Pacific countries are supporting the growth of the market in the region.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750
About
MarketsandMarkets™
MarketsandMarkets™
has been recognized as one of America's best management consulting
firms by Forbes, as per their recent report.
MarketsandMarkets™
is a blue ocean alternative in growth consulting and program management,
leveraging a man-machine offering to drive supernormal growth for progressive
organizations in the B2B space. We have the widest lens on emerging
technologies, making us proficient in co-creating supernormal growth for
clients.
Earlier
this year, we made a formal transformation into one of America's best
management consulting firms as per a survey conducted by Forbes.
The
B2B economy is witnessing the emergence of $25
trillion of new revenue streams that are substituting existing
revenue streams in this decade alone. We work with clients on growth programs,
helping them monetize this $25 trillion opportunity
through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought Leadership
Marketing.
Built
on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B
companies - helping them stay relevant in a disruptive ecosystem. Our insights
and strategies are molded by our industry experts, cutting-edge AI-powered
Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our
Market Intelligence Cloud) integrates our research, facilitates an analysis of
interconnections through a set of applications, helping clients look at the
entire ecosystem and understand the revenue shifts happening in their industry.
To
find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
According to the lastest report published by MarketsandMarkets, "Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027, the global synthetic biology market size is projected to reach USD 35.7 billion by 2027 from 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period.
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=889
Factors such as diversified applications of synthetic biology, rising R&D funding and growing initiatives in synthetic biology, declining cost of DNA sequencing and synthesizing, and increasing investments in the market are propelling the growth of this market.
The oligonucleotides and synthetic DNA segment accounted for the largest share of the tool segment in the synthetic biology market
Based on tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids., oligonucleotides & synthetic DNA accounted for the largest share of the synthetic biology market for tools. This segment's large share can be attributed to factors such as rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications.
The medical applications segment accounted for the largest share of the application segment in the synthetic biology market
Based on application, the synthetic biology market is categorized into three segments—medical applications, industrial applications, food & agriculture, and environmental applications. In 2021, medical applications segment accounted for the largest share of synthetic biology market. Factors such as the adoption of synthetic biology techniques and tools in regenerative medicine, use of synthetic biology tools in drug discovery and development are projecting the segmental growth.
Enquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889
Asia Pacific is likely to grow at higher double digit during the forecast period.
The Asia Pacific region is estimated to grow at the highest CAGR in the synthetic biology market during the forecast period, this is mainly due to factors such the increasing investment in research & development, emergence of new market players in synthetic biology market.
Key Market Players
Some of the prominent players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889
Don’t miss out on business opportunities in Synthetic Biology Market. Speak to our analyst and gain crucial industry insighs that will help your businessgrow.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The global primary cells market is projected to reach USD
2.8 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 10.5% during the
forecast period. The growth of this market can be attributed to factors such as
the is the growing advantages of primary human cells over cell lines, growth in
pharmaceutical & biotechnology industries, increasing demand for monoclonal
antibodies, government investments for cell-based research, and increasing
cancer research.
Request To
Download Sample of This Strategic Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960
Primary cells refer to cells taken directly from living
tissues of animals or humans and are then processed to establish them for use
in appropriate cell therapies. Primary cells are widely used in various
applications, including 3D cell culture, virology, cancer research, stem cell
therapy, and tissue replacement.
This study involved four major activities in estimating the
current size of the primary cells market. Exhaustive secondary research was
carried out to collect information on the market, its peer markets, and its
parent market. The next step was to validate these findings, assumptions, and
sizing with industry experts across the value chain through primary research.
North America is the largest regional market for primary
cells market
The primary cells market is segmented into four major
regions, namely, North America, Europe, Asia Pacific, and the Rest of the World
(RoW). North America accounted for the largest share in the primary cells
market. The growth in the North American primary cells market can be attributed
to increasing funding for cancer research, growing life science research
sector, expansion of the healthcare sector, and the high adoption of stem cell
therapy & cell immunotherapies for the treatment of cancer and chronic diseases.
Key
Market Players
Thermo Fisher
Scientific, Inc. (US), Merck KGaA (Germany), Lonza (Switzerland), Cell
Biologics, Inc. (US), PromoCell GmbH (Germany), HemaCare Corporation (US),
ZenBio, Inc. (US), STEMCELL Technologies, Inc. (Canada), Corning Incorporated
(US), AllCells (US), American Type Culture Collection (US), Axol Bioscience
Ltd. (UK), iXCells Biotechnologies (US), Neuromics (US), StemExpress (US),
BioIVT (US), ScienCell Research Laboratories, Inc. (US), PPA Research Group,
Inc. (US), Creative Bioarray (US), BPS Bioscience, Inc. (US), Epithelix Sàrl
(Switzerland), ReachBio LLC (US), AcceGen (US), Sekisui XenoTech, LLC (US), and
Biopredic International (France).
For a detailed look at our Table of Contents
@ https://www.marketsandmarkets.com/Market-Reports/primary-cells-market-32854960.html
This report categorizes the primary cells market into
the following segments and subsegments:
By Origin
By Type
By End User
By Region
Recent Developments
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=32854960
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on
30,000 high growth niche opportunities/threats which will impact 70% to 80% of
worldwide companies’ revenues. Currently servicing 7500 customers worldwide
including 80% of global Fortune 1000 companies as clients. Almost 75,000 top
officers across eight industries worldwide approach MarketsandMarkets™ for
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies, innovators, strategic players)
annually in high growth emerging segments. MarketsandMarkets™ is determined to
benefit more than 10,000 companies this year for their revenue planning and
help them take their innovations/disruptions early to the market by providing
them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and
market research platform, "Knowledgestore" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. The growth of the global biologics safety testing market is driven by factors such as the growing developments of biologics and biosimilars, increased concerns over the cell culture contamination, and rising investments in biopharmaceutical research and development.
Get Access to Sample Pages + Covid-19 impact analysis: https://www.marketsandmarkets.com/requestsampleNew.asp?id=34624144
Key Market Players
Prominent players in the biologics safety testing market are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Labcorp (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Sartorius AG (Germany), and Lonza (Switzerland).
CHARLES RIVER LABRATORIES (US)
Charles River is one of the key players in the biologics safety testing market. It is a service and early-stage contract research organization (CRO). The company develops a diverse portfolio of discovery & safety assessment services by providing a suite of products and services to support its clients’ manufacturing activities. The company operates through three reporting segments, namely, Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing).
LONZA (SWITZERLAND)
Lonza is a key player in the biologics safety testing market. The company has a large number of manufacturing and R&D facilities worldwide. The company's wide geographic presence and high production capacity deliver quality products worldwide.
THERMO FISCHER SCIENTIFIC (US)
Thermo Fisher Scientific offers analytical instruments, equipment, reagents, and consumables for research, discovery, analysis, diagnostics, and manufacturing. The company operates through four principal product segments—Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
For In-Depth Competitive Analysis, Read a Report: @ https://www.marketsandmarkets.com/Market-Reports/biologics-safety-testing-market-34624144.html
The Asia Pacific region is the fastest growing region of the Biologics safety testing market
The Asia Pacific market is projected to witness the highest growth rate during the forecast period. Rapid growth in outsourcing preclinical, clinical, and laboratory testing services to APAC countries is expected to drive market growth during the forecast period. Several companies are focusing on increasing their market shares and customer base in the region to capitalize on these opportunities in the Asia Pacific market.
Recent Developments
· Merck KGaA (Germany) invested in expanding its biosafety testing capacity at Rockville, Maryland, US. This site will provide biosafety testing and analytical development services in the US.
· Eurofins Scientific (Luxembourg) acquired Wessling Hungary, a food, environmental, and BioPharma product testing laboratory in Hungary. This acquisition helped expand Eurofins' biopharma testing business in Europe.
· Lonza (Switzerland) launched the PyroCell Monocyte Activation Test to detect non-endotoxin pyrogens and reduce interferences from complex drug products, such as biologics-based pharmaceuticals.
Buy-Now this Premium Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=34624144
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
The residential air purifiers market is projected to reach USD 14.1 billion by 2026 from USD 9.6 billion in 2021, at a CAGR of 8.1%. Residential air purifiers are the most effective devices to improve indoor air quality and to reduce or remove the sources of pollutants and to ventilate with clean air. These are designed to filter the air in a single room or area and reduce indoor air pollution.
Download Sample PDF Brochure of Residential Air Purifiers Market Size - Global Analysis with Strategic Insights at: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40172748
Residential Air Purifiers Market: Competitive Landscape and Key Developments
Daikin Industries, Ltd. (Japan), Sharp Corporation (Japan), Honeywell International Inc. (US), Samsung Electronics Co., Ltd. (South Korea), LG Electronics Inc. (South Korea), Koninklijke Philips N.V. (Netherlands), Dyson (UK), Unilever Group (UK), Panasonic Corporation (Japan), Whirlpool Corporation (US), AllerAir Industries Inc. (US), IQAir (Switzerland), Winix Co., Ltd. (South Korea), Xiaomi Corporation (China), Camfil AB (Sweden), Airpura Industries Inc. (Canada), Airgle Corporation (US), Hunter Pure Air (US), Kent RO Systems Ltd. (India), SHIL Limited (India), IDEAL Krug & Priester GMBH & Co. KG (Germany), Havells India Ltd. (India), Molekule (US), Carrier Global (US), and Coway CO., Ltd. (South Korea)
Panasonic Corporation (Japan) has developed a new nanoe X device that generates 100 times more Hydroxyl (OH) radicals than the conventional nanoe device. As a result, the latest nanoe X device delivers increased effectiveness in air purification and deodorization in indoor spaces.
Panasonic Ecology Systems Co., Ltd. (PES) and Panasonic Ecology Systems Guangdong Co., Ltd. built the First Shunde Branch Plant in China, a new factory for IAQ devices such as energy recovery ventilator systems and air purifiers.
Dyson (UK) opened its fourth Dyson Demo store in France, located in the iconic shopping district of Terrasses du Port in Marseille. The new space will showcase Dyson’s latest technology in home cleaning, air purification, lighting, and hair care.
Inquiry Before Purchase: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=40172748
Objectives of the Study
Speak to Research Expert: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=40172748
Global Residential Air Purifiers Market – Regional Scope
The global residential air purifiers market is segmented into four major regions; North America, Europe, Asia-Pacific, and the Rest of the World.
North America: In the North American region, the residential air purifiers market is driven by the presence of several key players such as Honeywell, Whirlpool, and Dyson. The US is the largest market in North America, followed by Canada and Mexico. High levels of pollution and air quality concerns are the major drivers of the residential air purifiers market in this region.
Europe: In the European region, the residential air purifiers market is driven by the presence of several key players such as Philips, LG, and Panasonic. Growing awareness about the health effects of air pollution and the availability of advanced air purifiers are the major drivers of the residential air purifiers market in this region.
Asia-Pacific: In the Asia-Pacific region, the residential air purifiers market is driven by the presence of several key players such as Daikin, Sharp, and Panasonic. Increasing urbanization, rising levels of air pollution, and the availability of advanced air purifiers are the major drivers of the residential air purifiers market in this region.
Rest of the World: In the Rest of the World region, the residential air purifiers market is driven by the presence of several key players such as Blueair, Coway, and Philips. Increasing awareness about the health effects of air pollution and the availability of advanced air purifiers are the major drivers of the residential air purifiers market in this region.
Buy Premium Copy of Residential Air Purifiers Market Growth Report (2021-2026) at: https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=40172748
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Single-Use Bioreactors Market in terms of revenue was estimated to be worth $4.2 billion in 2023 and is poised to reach $10.0 billion by 2028, growing at a CAGR of 19.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750
Factors such as the increasing adoption of single-use bioreactors among startups and SMEs, lower operational complexity of single-use bioreactors compared to conventional stainless-steel bioreactors, reduced energy and water consumption, growing size of the biologics and biosimilars market, and technological advancements in single-use bioreactors.
Browse in-depth TOC on "Single-Use Bioreactors Market"
408 - Tables
48 - Figures
345 – Pages
TOP Single-Use Bioreactors MARKET PLAYER
The single-use bioprocessing market is highly consolidated with majority of the market share taken up by key players such as Thermo Fisher Scientific (US), Danaher Corporation (US), Sartorius Stedim Biotech S.A. (France), and Merck KGaA (Germany). The key players in this market are increasingly focusing on strategic expansions, partnerships, and product approvals to expand their manufacturing capabilities and increase market presence.
Sartorius Stedim Biotech held the leading position in the single-use bioprocessing market. Sartorius focuses on strengthening its position in the market by adopting organic and inorganic strategies such as product launches and expansions. During the past three years, Sartorius Stedim Biotech launched SUB systems such as BIOSTAT STR Generation 3 Single-Use Bioreactor, BIOSTAT RM TX Single-Use Bioreactor, and BIOSTAT STR. Sartorius acquired Danaher’s Life Science portfolio, which is complementary to the portfolio of Sartorius’s laboratory and bioprocess business. the company also expanded their operations in Puerto Rico.
Thermo Fisher Scientific is the second-largest player in the single-use bioprocessing market. Thermo Fisher Scientific operates in the single-use bioprocessing market through the life science solutions business segment. To further increase its share in the single-use bioprocessing market, the company focuses on growth strategies such as acquisitions and expansion. the company expanded its business in the US. The company also made investments worth ~USD 650 million to enhance their single-use bioprocessing capabilities and increase their market share.
The Asia Pacific region is the fastest-growing region of the single-use bioreactors market.
Based on the region, the single-use bioreactors market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest CAGR during the forecast period. Factors such as the growing biopharmaceutical industry, rising investments by pharmaceutical & biotechnology companies, and the growing number of CROs & CMOs in several Asia Pacific countries are supporting the growth of the market in the region.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=49113750
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Patient Monitoring Devices Market is projected to grow from USD 42.3 billion in 2022 to USD 65.4 billion by 2027, at a CAGR of 9.1% from 2022 to 2027, according to a new report by MarketsandMarkets™. The evolution of the market is primarily driven by the rising number of hospitals across major markets, growing cognizance about vital parameter monitoring for treatment and analysis of chronic diseases coupled with the growing adoption of wireless and wearable patient monitoring devices for homecare. Additionally, expansion of developmental pipeline of OEMs for connected care & integrated/multi-parameter patient monitoring devices is poised to further augment the market growth in coming decade.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678
Browse in-depth TOC on “Patient Monitoring Devices Market”
349 — Tables
41 — Figures
391 — Pages
Based on the product, the patient monitoring devices market is segmented into hemodynamic/pressure monitoring devices, multiparameter monitoring devices, neuromonitoring devices, fetal and neonatal monitoring devices, blood glucose monitoring systems, weight monitoring devices, respiratory monitoring devices, temperature monitoring devices, cardiac monitoring devices, and other patient monitoring devices. The cardiac monitoring devices products segment is further classified into smart/wearable ECG monitors, event monitors, ECG devices, mobile cardiac telemetry (MCT) monitors, and implantable loop recorders (ILRs). Within the cardiac monitoring devices products, the ECG devices division held a major part of the market in 2021. Emerging use cases of ECG devices and higher adoption of portable or wireless cardiac monitors are a major factor influencing to the growth of this market segment.
The hospital end user segment is expected to indicate the highest growth rate during the forecast period.
Based on end users, the patient monitoring devices market has been segmented into hospitals, ambulatory surgery centers, home care settings and other end users, Dominant market position of the hospitals segment can be credited to the presence of well-equipped emergency wards and ICUs in hospitals and the rising number of surgeries.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=678
North America is likely to lead the global patient monitoring devices market in 2021.
North America, encompassing the US and Canada, reported for the major split of the patient monitoring devices market in 2021. An growing quantity of clinical trials verifying patient monitoring devices and a rising amount of approvals for patient monitoring. Are the major factors driving market growth in North America. Customers in North America are shifting towards homecare patient monitoring, that requires non-invasive patient monitoring devices. This trend will have a definite impact on the patient monitoring device market.
As of 2021, Abbott Laboratories (US), HILL-ROM HOLDINGS, INC. (US), Drägerwerk AG & Co. KGaA (Germany), Edwards Lifesciences Corporation (US), OMRON Corporation (Japan), Masimo Corporation (US), Compumedics Limited (Australia), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Nihon Kohden Corporation (Japan), Natus Medical (US), Medtronic plc (Ireland), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Getinge AB (Sweden), Boston Scientific Corporation (US), Dexcom, Inc. (US), Nonin (US), BIOTRONIK (Germany), SCHILLER (Switzerland), and BioTelemetry, Inc. (the US), among others are some of the major players operating in the global patient monitoring devices market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=678
According to the new market research report “Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026.
Browse in-depth TOC on “Peripheral Vascular Devices Market”
499 – Tables
43 – Figures
347 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=790
The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.
Hemodynamic flow alteration devices in the product segment to witness the highest growth during the forecast period.
Based on the product, the peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=790
North America dominates the global peripheral vascular devices market.
The peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America accounted for the largest share of the market. The large share of North America can be attributed to the growth in the geriatric population and the high prevalence of peripheral vascular diseases. Furthermore, the presence of key market players in this region ensures high access to medical devices
The major players in the peripheral vascular devices market Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=790